Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 13
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00267722 | Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease | ||
NCT00502294 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis | ||
NCT00279435 | Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study | ||
NCT00279422 | A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis | ||
NCT00355901 | An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis | ||
NCT00548717 | Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation | ||
NCT00267306 | Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis | ||
NCT00099970 | Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy | ||
NCT00267709 | Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease | ||
NCT00014664 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | ||
NCT00281294 | A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis | ||
NCT00325793 | IV Double and Triple Concentrated Nicardipine for Stroke and ICH | ||
NCT00109161 | Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis |